Antibiotic resistance in Pseudomonas aeruginosa: An Italian survey

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 2, 1998, Pages 307-310

  Bonfiglio, Giovanni ^a,b   Carciotto, Vincenzo ^a   Russo, Giovanni ^a   Stefani, Stefania ^a   Schito, Gian Carlo ^a   Debbia, Eugenio ^a   Nicoletti, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GRAM NEGATIVE INFECTION; HUMAN; ITALY; PSEUDOMONAS AERUGINOSA;

EID: 0031892008     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.2.307     Document Type: Article

References (10)

1. Curtis, N. A. C., Eisenstadt, R. L, Rudd, C. & White. A. J. (1986). Inducible type-l β-lactamase of Gram-negative bacteria and resistance to /Mactam antibiotics. Journal of Antimicrobial Chemotherapy 17,51-61.
2. Jacoby, G. A. & Sutton, L. (1979). Activity of /Mactam antibiotics against Pseudomonas aeruginosa isolates carrying R-plasmids determining different β-lactamases. Antimicrobial Agents and Chemotherapy 16, 243-5.
3. Shannon, K. & Phillips, I. (1982). Mechanisms of resistance to aminoglycosides in clinical isolates. Journal of Antimicrobial Chemotherapy 9,91-102.
4. lyobe, S., Hirai, K. & Hashimoto, H. (1991). Drug resistance in Pseudomonas aeruginosa with special reference to new quinolones. In Pseudomonas aeruginosa in Human Disease (Homma, J. Y., Tanimoto, H., Holder, I. A., Hoiby, N. & Doring, G., Eds), pp. 209-14. Karger, Basle.
5. Buscher, K. H., Cullmann, W., Dick, W. & Opferkuch. W. (1987). Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrobial Agents and Chemotherapy 31,703-8.
6. Li, X.-Z., Ma, D., Livermore, D. M. & Nikaido, H. (1994). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: . active efflux as a contributing 'factor to /Mactam resistance. Antimicrobial Agents and .Chemotherapy 38,1742-52.
7. National Committee for Clinical Laboratory Standards. (1995). Standard Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria which Grow Aerobically; Approved Standard M7-A2. NCCLS, Villanova, PA.
8. Chen, H. Y., Yuan, M., Ibrahim-Elmagboul, I. B. & Livermore, D. M. (1995). National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 35,521-34.
9. Fung-Tomc, J. C., Huczko, E., Banville, J., Menard, M., Kolek, B., Gradelski, E. et al. (1995). Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy39,394-9.
10. Sumita, Y. & Fukasawa, M. (1996). Meropenem resistance in Pseudomonas aeruginosa. Chemotherapy 42,47-56.